 NEW YORK, April 6, 2021 PRNewswire -- Pomerantz LLP is investigating claims on behalf of investors of Aquestive Therapeutics, Inc. Aquestive or the Company NASDAQ: AQST. Such investors are advised to contact Robert S. 